JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2016, Vol. 18 ›› Issue (6): 513-517.DOI: 10.3969/j.issn.1671-2587.2016.06.001
• Original Articles • Next Articles
Received:
2016-08-28
Online:
2016-12-20
Published:
2016-12-23
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lcsxyjy.com/EN/10.3969/j.issn.1671-2587.2016.06.001
1 国务院.促进大数据发展行动纲要[S].2015-8-31. 2 K. Pendry. The use of big data in transfusion medicine[J]. Transfus Med,2015,25(3):129-137. 3 Herland M,Khoshgoftaar TM,Wald R. A review of data mining using big data in health informatics[J].J Big Data,2014,1(2):1-35. 4 庞涛. 合理地利用来源于清晰的认知——英特尔中国医疗卫生首席架构师吴闻新谈医疗大数据的认识与利用[J]. 中国信息界:e医疗,2014,7(6):46-48. 5 艾媒咨询:2015-2016中国移动医疗健康市场研究报告.http://www.iimedia.cn/40530.html. 6 邱艳.Haemovigilance的发展现状及思考[J].北京医学,2009,31(2):111-113. 7 高岩,邱艳.血液质量管理的有效工具Haemovigilance 8 .中国输血杂志,2015,28(9):1154-1158. 9 WHO.http://www.who.int./bloodsafety/haemovigilan-ce/global_consultation/en/. WHO Global Consultation on Haemovigilance.2012-11-22 [2014-08-22]. 10 9Vuk T. Quality indicators in blood establishments: ISBT Working Party on Quality Management Project [J]. Transfus Today,2013,96(1):10-11. 11 Apelseth TO,Molnar L,Arnold E,et al. Benchmarking:applications to transfusion medicine[J]. Transfus Med Rev,2012,26(4):321-332. 12 Amina ET,Marie L,Philippe M,et al. Benchmarking. A Method for Continuous Quality Improvement in Health[J]. Healthc Policy,2012,7(4):e101-119. 13 Eiff WV. International Benchmarking and Best Practice Management:In Search of Health Care and Hospital Excellence[J]. Adv in Health Care Manag,2015,93(17):223-252. 14 邱艳,刘江. 亚太血液联盟:亚太地区输血事业共同发展的交流平台[J].中国输血杂志,2014,27(7),786-788. 15 Saxena S,Ramer L,Shulman IA. A comprehensive assessment program to improve blood-administering practices using the FOCUS-PDCA model[J]. Transfus,2004 ,44(9):1350-1356. 15 中国合格评定国家认可委员会.CNAS-CL01 检测和校准实验室能力认可准则(ISO/IEC17025:2005). 2006-07-01. 16 CNAS-CL02医学实验室质量和能力认可准则(ISO15189:2007).2008-12-01. 17 Wagstaff W. GMP in blood collection and processing[J].Vox Sang,1998,74(Suppl 2):513-521. 18 http://www.who.int/medicines/areas/quality_safety/regulation_legislation/certification/guidelines/en/. 19 WHO guidelines on good manufacturing practices for blood establishments. WHO Technical Report Series,No. 961,2011. 20 Current Good Manufacturing Practice for Blood and Blood Components.e-CFR data FDA,Title 21: Food and Drugs,Part 606.2015-11. 21 临床实验室检验及体外诊断检测系统技术委员会.医学实验室———质量和能力专用要求.ISO15189:2003. |
[1] | JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141. |
[2] | WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185. |
[3] | GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188. |
[4] | DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191. |
[5] | YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196. |
[6] | GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis:Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212. |
[7] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239. |
[8] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241. |
[9] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255. |
[10] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262. |
[11] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272. |
[12] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17. |
[13] | HAO Yi-wen. Evaluating Indications for Red Blood Cell Transfusion and Therapeutic Efficacy:An Overall and Dynamic View [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 590-593. |
[14] | HUANG Rong, CHEN Ting-ting, ZHU Long-fei, et al. Blood Transfusion in Maternal Neonatal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 610-612. |
[15] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 613-616. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||